Once approved, the 5-HT6 receptor antagonist can be marketed and prescribed to patients. Post-marketing surveillance continues to monitor the drug's safety and effectiveness in the broader population.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
N-[4-(6-chloro-2-isopropylamino-pyrimidin-4-ylsulfamoyl)-phenyl]-acetamide
C17H13N3O4S3
